Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.

Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...

Radon, an odorless radioactive gas that seeps from soil into homes, is responsible for an estimated 21,000 lung cancer deaths each year in the United States. That figure, drawn from federal risk ...

'Thousands more people today can make memories, reach milestones, and spend precious time with their loved ones' ...

Aging is associated with increased risk for nearly every lung disease, including acute conditions like pneumonia and chronic diseases like chronic obstructive pulmonary disease, idiopathic pulmonary ...

Incyte announced Friday that the FDA issued a complete response letter for its PD-1 inhibitor Zynyz as a first-line treatment for non-small cell lung cancer.

Learn how to tell the difference between these two common symptoms.

Researchers have found hundreds of metabolic enzymes attached to human DNA inside the cell nucleus. Different tissues and cancers show unique patterns of these enzymes, forming a “nuclear metabolic ...

Nanjing Leads Biolabs Co., Ltd. ('Leads Biolabs' or the 'Company,' Stock Code: 9887.HK) announced on March 6, 2026 that the ...

Free health testing for Wichita-area residents who spent time around groundwater contamination near 29th and Grove is now available through a coordinated initiative that will connect them to clinics ...

Breakthrough immunotherapy trials are showing unprecedented responses in a subset of rectal cancer patients, hinting at a ...

Kaposi sarcoma-associated herpesvirus testing is not routinely performed on donors or reci ...